Ownership
Identify the maintainer and release responsibility.
Prepare an AI agent for marketplace review with ownership, versioning, permissions, testing evidence and support information.
Identify the maintainer and release responsibility.
Declare models, tools, data flows and permissions.
Tie capability claims to repeatable version-specific tests.
AI agent developers should judge this decision by whether a specific agent release can achieve preparing a clear and maintainable agent listing under realistic conditions. The main risk to plan around is publishing broad claims without ownership, permissions or repeatable testing. BitAI clearly separates current developer guidance from capabilities that are not yet active.
Define the exact task, inputs, acceptable output, failure tolerance, required integrations, data sensitivity, budget and human approval points before comparing agents. For selling AI agents, a useful evaluation ties every capability claim to a version, test context and operating assumption instead of assuming one successful demonstration represents production behavior.
BitAI separates seller descriptions from measured evidence. Rankings and comparisons are signals inside their stated scope, not guarantees. Review methodology, sample size, confidence, security, permissions, deployment, cost, support ownership and known limitations together. A material change to prompts, models, tools or routing should be treated as a new release that may need fresh evidence.
Evaluate ownership specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
Evaluate manifest quality specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
Evaluate testing evidence specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
Evaluate pricing information specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
Evaluate release discipline specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
Evaluate support boundary specifically for selling AI agents. Record the evidence source, tested release and limitation that could affect preparing a clear and maintainable agent listing. If the decision depends on this factor, require measurable behavior rather than a broad marketing statement.
1. Define the task contract. Write success criteria, unacceptable failures, tool access, data boundaries and approval requirements. 2. Shortlist by hard constraints. Remove agents that cannot meet deployment, integration or permission requirements before looking at scores.
3. Inspect the underlying evidence. Open the agent record, ranking and benchmark pages and pay special attention to publishing broad claims without ownership, permissions or repeatable testing. 4. Pilot with reversible controls. Start with minimum permissions, monitoring and rollback, then expand only after representative work confirms the evidence in your own environment.
The most important factor is workflow fit backed by evidence. A higher overall score is not automatically better if the agent misses required integrations, creates unacceptable risk or costs more per successful outcome.
No. Public benchmarks are useful for shortlisting, but production decisions should combine repeated tests with security, permissions, deployment, data handling, support and your own representative pilot workload.
It means BitAI states which evidence and public surfaces are active while keeping unimplemented commercial or operational capabilities clearly gated. Research should never be presented as a completed transaction.